[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100563546":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":19,"responsibleParty":162,"collaborators":7,"id":164,"slug":165,"hasResults":166,"nctId":167,"briefTitle":168,"officialTitle":169,"acronym":7,"eligibilityCriteria":170,"healthyVolunteers":166,"sex":171,"minAge":172,"maxAge":7,"enrollmentInfo":7,"targetDuration":7,"studyType":173,"phases":7,"briefSummary":174,"conditions":175,"keywords":7,"overallStatus":22,"whyStopped":7,"lastUpdateSubmitDate":178,"lastUpdatePostDateStruct":179,"startDateStruct":7,"completionDateStruct":7,"leadSponsor":182,"locationsCount":184},{"fullName":5,"class":6},"USWM, LLC (dba US WorldMeds)","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"GENETIC","Non-conforming afamitresgene autoleucel","Non-conforming afamitresgene autoleucel, suspension for intravenous infusion (NC afami-cel), single dose administration",[14],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Clinical Scientist","CONTACT","866-750-8796","kathleen.derose@usworldmeds.com",[20,38,51,64,76,89,102,111,124,136,149],{"facility":21,"status":22,"city":23,"state":24,"zip":25,"country":26,"countryCode":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"Mayo Arizona","AVAILABLE","Phoenix","Arizona","85259","United States","US",{"type":29,"coordinates":30},"Point",[31,32],-112.07404,33.44838,{"lat":32,"lon":31},[35],{"name":36,"role":37,"phone":7,"phoneExt":7,"email":7},"Mahesh Seetharam, MD","PRINCIPAL_INVESTIGATOR",{"facility":39,"status":22,"city":40,"state":41,"zip":42,"country":26,"countryCode":27,"cosmosGeoPoint":43,"geoPoint":47,"contacts":48},"Stanford Hospital and Clinics","Stanford","California","94305",{"type":29,"coordinates":44},[45,46],-122.16608,37.42411,{"lat":46,"lon":45},[49],{"name":50,"role":37,"phone":7,"phoneExt":7,"email":7},"Kristen Ganjoo, MD",{"facility":52,"status":22,"city":53,"state":54,"zip":55,"country":26,"countryCode":27,"cosmosGeoPoint":56,"geoPoint":60,"contacts":61},"Mayo Florida","Jacksonville","Florida","32224",{"type":29,"coordinates":57},[58,59],-81.65565,30.33218,{"lat":59,"lon":58},[62],{"name":63,"role":37,"phone":7,"phoneExt":7,"email":7},"Steven Attia, MD",{"facility":65,"status":22,"city":66,"state":54,"zip":67,"country":26,"countryCode":27,"cosmosGeoPoint":68,"geoPoint":72,"contacts":73},"Moffit Cancer Center","Tampa","33612",{"type":29,"coordinates":69},[70,71],-82.45843,27.94752,{"lat":71,"lon":70},[74],{"name":75,"role":37,"phone":7,"phoneExt":7,"email":7},"Mihaela Druta, MD",{"facility":77,"status":22,"city":78,"state":79,"zip":80,"country":26,"countryCode":27,"cosmosGeoPoint":81,"geoPoint":85,"contacts":86},"Northwestern University Feinberg School of Medicine","Chicago","Illinois","60601",{"type":29,"coordinates":82},[83,84],-87.65005,41.85003,{"lat":84,"lon":83},[87],{"name":88,"role":37,"phone":7,"phoneExt":7,"email":7},"Seth Pollack, MD",{"facility":90,"status":22,"city":91,"state":92,"zip":93,"country":26,"countryCode":27,"cosmosGeoPoint":94,"geoPoint":98,"contacts":99},"Massachusetts General Hospital","Boston","Massachusetts","02144",{"type":29,"coordinates":95},[96,97],-71.05977,42.35843,{"lat":97,"lon":96},[100],{"name":101,"role":37,"phone":7,"phoneExt":7,"email":7},"Edwin Choy, MD",{"facility":103,"status":22,"city":91,"state":92,"zip":104,"country":26,"countryCode":27,"cosmosGeoPoint":105,"geoPoint":107,"contacts":108},"Dana-Farber Cancer Institute","02215",{"type":29,"coordinates":106},[96,97],{"lat":97,"lon":96},[109],{"name":110,"role":37,"phone":7,"phoneExt":7,"email":7},"Michael Wagner, MD",{"facility":112,"status":22,"city":113,"state":114,"zip":115,"country":26,"countryCode":27,"cosmosGeoPoint":116,"geoPoint":120,"contacts":121},"Mayo Rochester","Rochester","Minnesota","55905",{"type":29,"coordinates":117},[118,119],-92.4699,44.02163,{"lat":119,"lon":118},[122],{"name":123,"role":37,"phone":7,"phoneExt":7,"email":7},"Steven Robinson, MD",{"facility":125,"status":22,"city":126,"state":126,"zip":127,"country":26,"countryCode":27,"cosmosGeoPoint":128,"geoPoint":132,"contacts":133},"Memorial Sloan Kettering Cancer Centre","New York","10065",{"type":29,"coordinates":129},[130,131],-74.00597,40.71427,{"lat":131,"lon":130},[134],{"name":135,"role":37,"phone":7,"phoneExt":7,"email":7},"Sandra D Angelo, MD",{"facility":137,"status":22,"city":138,"state":139,"zip":140,"country":26,"countryCode":27,"cosmosGeoPoint":141,"geoPoint":145,"contacts":146},"Fox Chase Cancer Center","Philadelphia","Pennsylvania","19111",{"type":29,"coordinates":142},[143,144],-75.16362,39.95238,{"lat":144,"lon":143},[147],{"name":148,"role":37,"phone":7,"phoneExt":7,"email":7},"Henry Fung, MD",{"facility":150,"status":22,"city":151,"state":152,"zip":153,"country":26,"countryCode":27,"cosmosGeoPoint":154,"geoPoint":158,"contacts":159},"MD Anderson Cancer Center","Houston","Texas","77030",{"type":29,"coordinates":155},[156,157],-95.36327,29.76328,{"lat":157,"lon":156},[160],{"name":161,"role":37,"phone":7,"phoneExt":7,"email":7},"Dejka Araujo, MD",{"type":163,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100563546","expanded-access-protocol-eap-for-nonconforming-nc-afami-cel-100563546",false,"NCT06617572","Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel","Expanded Access Protocol for Product Which Does Not Conform to the TECELRA® (Afamitresgene Autoleucel, Suspension for Intravenous Infusion) Commercial Release Specification","Inclusion Criteria:\n\n* Patient must provide written informed consent prior to participating in this protocol\n* Patient must have been prescribed TECELRA®\n* Patient's commercially manufactured product does not meet the commercial release specification\n* Repeat manufacture is not feasible or is not clinically appropriate per Investigator assessment in consultation with Adaptimmune\n* Repeat leukapheresis is not feasible or is not clinically appropriate per Investigator assessment\n* The Investigator has confirmed a favorable benefit:risk profile, following sponsor evaluation of the NC afami-cel, and deems proceeding with treatment under this EAP is in the best interest of the patient\n* Patient deemed medically fit and stable to receive NC afami-cel per Investigator assessment\n* Female patients with reproductive potential must have a negative serum or urine pregnancy test within 7 days of initiating lymphodepleting chemotherapy\n\nExclusion Criteria:\n\n* Patient has contraindication(s) as per the TECELRA® USPI\n* Do not use TECELRA® in adults who are heterozygous or homozygous for HLA-A\\*02:05P","ALL","18 Years","EXPANDED_ACCESS","The purpose of this expanded access protocol (EAP) is to provide controlled access to Afamitresgene autoleucel, suspension for intravenous infusion that does not meet the commercial release specification (NC afami-cel). This EAP will be conducted at authorized treatment centers where TECELRA® is being administered and where the EAP is approved to be conducted. Patients who are prescribed TECELRA® , sign the informed consent form, and meet all entry criteria will be eligible to participate in this protocol.",[176,177],"Synovial Sarcoma","Myxoid Liposarcoma","2026-02-05",{"date":180,"type":181},"2026-02-09","ACTUAL",{"name":183,"class":6},"USWM CT, LLC",11]